NCT07411040

Brief Summary

This study aims to investigate the effects of Body Awareness Therapy on physical and psychosocial outcomes in adults with asthma. Asthma is a chronic respiratory condition that can affect breathing, physical activity, and emotional well-being. In addition to medical treatment, non-pharmacological approaches that support body awareness and breathing may help individuals manage their symptoms more effectively. Participants in this study will be randomly assigned to either a Body Awareness Therapy group or a control group receiving standard care. The Body Awareness Therapy program includes guided exercises focusing on posture, breathing, movement, and awareness of bodily sensations. The program will be delivered over several weeks by a trained physiotherapist. The main outcomes of the study include physical function, respiratory symptoms, quality of life, psychological well-being, and body awareness levels. The results of this study are expected to provide evidence on whether Body Awareness Therapy can be an effective supportive approach in asthma management and rehabilitation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P25-P50 for not_applicable asthma

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable asthma

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

January 31, 2026

Last Update Submit

February 6, 2026

Conditions

Keywords

asthmabody awarenessbody awareness therapy

Outcome Measures

Primary Outcomes (2)

  • Six-Minute Walk Test Distance

    Physical function will be assessed using the Six-Minute Walk Test (6MWT). Total walking distance covered in six minutes will be recorded. (Units of Measure: Meters)

    Baseline (Week 0) and Post-intervention (Week 8)

  • Asthma Control Test Total Score

    Asthma symptom severity will be assessed using the Turkish Asthma Control Test (T-ACT). The total questionnaire score will be analyzed.

    Baseline (Week 0) and Post-intervention (Week 8)

Study Arms (2)

Body Awareness Therapy Group

EXPERIMENTAL

Participants will receive a structured Body Awareness Therapy program delivered by a trained physiotherapist.

Behavioral: Body Awareness TherapyOther: Standart Care

Standard Care Control Group

ACTIVE COMPARATOR

Participants will receive standard medical care for asthma without additional body awareness intervention.

Other: Standart Care

Interventions

A structured Body Awareness Therapy program delivered by a trained physiotherapist, including guided exercises focusing on breathing awareness, posture, gentle movement, and attention to bodily sensations.

Body Awareness Therapy Group

Participants will continue their usual medical care for asthma without additional body awareness intervention.

Body Awareness Therapy GroupStandard Care Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 18 and 65 years.
  • Clinically diagnosed asthma confirmed by a physician.
  • Stable asthma condition (no acute exacerbation in the last 4 weeks).
  • Receiving regular medical treatment for asthma.
  • Able to understand and follow instructions for the intervention.
  • Willing to participate and provide written informed consent.

You may not qualify if:

  • Diagnosis of chronic respiratory diseases other than asthma (e.g., COPD, bronchiectasis).
  • Acute asthma exacerbation within the last 4 weeks.
  • Severe cardiovascular, neurological, or musculoskeletal conditions that may limit participation in physical activity.
  • Current participation in another structured exercise or rehabilitation program.
  • History of major psychiatric disorders that may interfere with participation (e.g., psychotic disorders).
  • Pregnancy.
  • Cognitive impairment affecting the ability to follow instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups: an intervention group receiving Body Awareness Therapy and a control group receiving standard care. Outcomes will be compared between groups at baseline and after completion of the intervention period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

January 31, 2026

First Posted

February 13, 2026

Study Start

February 1, 2026

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

February 13, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared publicly due to ethical and privacy considerations, as the data include sensitive personal and health-related information. Data will be used only for the purposes of the current study and stored in accordance with institutional and data protection regulations.